Suprachoroidal Injection of Triamcinolone Acetonide With IVT Aflibercept in Subjects With Macular Edema Following RVO
Clinical trial NCT02980874 · TERMINATED
Trial details
- NCT number
- NCT02980874
- Sponsor
- Clearside Biomedical, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-01-31
- Primary completion
- 2018-12-10
- Enrollment
- 460
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.